Skip to main content
SpringerLink
Log in
Book cover

The New Dimensions of Warfarin Prophylaxis pp 55–66Cite as

Warfarin and Bone: Implications for Rational Strategies to Selectively Antagonize the Action of Vitamin K in Target Tissues

  • Chapter

  • 176 Accesses

Abstract

We have recently reported that vitamin K counteracts the action of Warfarin on blood coagulation but not on the synthesis of bone Gla protein (BGP; osteocalcin) (1). The purpose of this paper is to describe the observations which led to this discovery and the implications of this discovery for Warfarin prophylaxis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Paul A. Price and Yuri Kaneda, Vitamin K counteracts the effect of Warfarin in liver but not in bone, Thrombosis Research, (Submitted 1986).

    Google Scholar 

  2. Paul A. Price, Vitamin K-dependent formation of bone Gla protein (Osteocalcin) and its function, Vitamins and Hormones 42:65–108 (1985).

    Article  Google Scholar 

  3. P.A. Price, J.W. Poser, and N. Raman, Primary structure of the y- carboxyglutamic acid-containing protein from bovine bone, Proc. Natl. Acad. Sci. USA 73:3374–3375 (1976).

    Article  PubMed  CAS  Google Scholar 

  4. P.A. Price and M.K. Williamson, Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein, J. Biol. Chem. 260:14971–14975 (1985).

    PubMed  CAS  Google Scholar 

  5. Lydia C. Pan and P.A. Price, The propeptide of rat bone y- carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors, Proc. Natl. Acad. Sci. USA 82:6109–6113 (1985).

    Article  PubMed  CAS  Google Scholar 

  6. Lydia C. Pan, Matthew K. Williamson, and P.A. Price, Sequence of the precursor to rat bone y-carboxyglutamic acid protein that accumulates in Warfarin-treated osteosarcoma cells. J. Biol. Chem. 260:13398–13401 (1985).

    PubMed  CAS  Google Scholar 

  7. S.K. Nishimoto and P.A. Price, The vitamin K-dependent bone pro- tein is accumulated within cultured osteosarcoma cells in the presence of the vitamin K antagonist Warfarin. J. Biol. Chem. 260:2832–2836 (1985).

    PubMed  CAS  Google Scholar 

  8. P.A. Price, M.K. Williamson, and J.W. Lothringer, Origin of the bone y-carboxyglutamic acid-containing protein found in plasma and its clearance by kidney and bone. J. Biol. Chem. 256:12760–12766 (1981).

    PubMed  CAS  Google Scholar 

  9. P.A. Price and S.K. Nishimoto, Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma, Proc. Natl. Acad. Sci. USA 77:2234–2238 (1980).

    Article  PubMed  CAS  Google Scholar 

  10. P.A. Price and M.K. Williamson, Effects of Warfarin on bone. Stu- dies on the vitamin K-dependent protein of rat bone, J. Biol. Chem. 256:12754–12759 (1981).

    PubMed  CAS  Google Scholar 

  11. P.A. Price, M.K. Williamson, T. Haba, R.B. Dell, and W.S.S. Jee, Excessive mineralization with growth plate closure in rats on chronic Warfarin treatment, Proc. Natl. Acad. Sci. USA 79:7734–7738 (1982).

    Article  PubMed  CAS  Google Scholar 

  12. J. Lowenthal and J.A. MacFarlane, The nature of the antagonism between vitamin K and indirect anticoagulants, J. Pharmacol. Exp. Ther. 143:273–277 (1964).

    PubMed  CAS  Google Scholar 

  13. A.K. Willingham and J.T. Matschiner, Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat, Biochem. J. 140:435–441 (1974).

    PubMed  CAS  Google Scholar 

  14. R. Wallin, S.D. Patrick, and T.D. Ballard, Vitamin K antagonism of coumarin intoxication in the rat Ihromb. Haemost. 55:235–239 (1986).

    CAS  Google Scholar 

  15. J.G. Hall, R.M. Pauli, K.M. Wilson, Maternal and fetal sequelae of anticoagulation during pregnancy Am. J. Med. 68:122–140 (1980).

    Article  PubMed  CAS  Google Scholar 

  16. J.W. Poser and P.A. Price, A method for decarboxylation of y- carboxyglutamic acid in proteins, J. Biol. Chem. 254:431–436 (1979).

    PubMed  CAS  Google Scholar 

  17. M.J. Thierry and J.W. Suttie, Effect of warfarin and the chloro analog of vitamin K Arch. Biochem. Biophvs. 147:430–435 (1971).

    Article  CAS  Google Scholar 

  18. P.A. Price and S.A. Sloper, The effect of Warfarin administration on the bone response to 1, 25-dihydroxyvitarnin D3, in: Endocrine Control of Bone and Calcium Metabolism, D.V. Chu, eéd., pp. 69–72 (1984).

    Google Scholar 

  19. P.A. Price and S.A. Baukol, 1, 25-dihydroxyvitamain D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J. Biol. Chem. 255:11660–11663 (1980).

    PubMed  CAS  Google Scholar 

  20. D.M. Stern, P.P. Nawroth, K. Harris, and C.T. Esmon, Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va , J. Biol. Chem. 261:713–718 (1986).

    PubMed  CAS  Google Scholar 

  21. D.S. Fair, R.A. Marlar, and E.G. Levin, Human endothelial cells synthesize protein S, Blood 67:1168–1171 (1986).

    PubMed  CAS  Google Scholar 

  22. B. Osterud and A Bjørklid, Human factor VII associated with endo- toxin stimulated monocytes in whole blood, Biochem. Bionhvs. Res. Comm. 108:620–626 (1982).

    Article  CAS  Google Scholar 

  23. B.P. Tsao, D.S. Fair, L.E. Curtiss, and T.S. Edgington, Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity, J. Exp. Med. 159:1042–1057 (1984).

    Article  PubMed  CAS  Google Scholar 

  24. B. Østerud, U. Lindahl, and R. Seljelid, Macrophages produce blood coagulation factors, FEBS Letters 120:41–43 (1980).

    Article  PubMed  Google Scholar 

  25. U. Lindahl, S.O. Kolset, J. Bögwald, B. Østerud, and R. Seljelid, Studies, with a 1uminogenie peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages, Biochem. J. 206:231–237 (1982).

    PubMed  CAS  Google Scholar 

  26. H.A. Chapman, Jr., C.L. Allen, and O.L. Stone, Human alveolar macrophages synthesize factor VII in vitro, J. Clin. Invest. 75:2030–2037 (1985).

    Article  PubMed  Google Scholar 

  27. M. Colucci, F. Delaini, G. Vitti DeBellis, D. Locati, A. Poggi, N. Semeraro, and M.B. Donati, Warfarin inhibits both procoagu-lant activity and metastatic capacity of Lewis Lung carcinoma cells, Role of vitamin K Deficiency. Biochem Pharm. 32:1689–1691 (1983).

    Article  PubMed  CAS  Google Scholar 

  28. B.L. Neubauer, K.G. Bemis, K.L. Best, R.L. Goode, D.M. Hoover, G.F. Smith, L.R. Tanzer, and R.L. Merriman, Inhibitory effect of Warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat J. Urol. 135:163–166 (1986).

    PubMed  CAS  Google Scholar 

  29. N.L.M. Goeting, G.A. Trotter, and I. Taylor, Effect of warfarin on formation and growth of pre-neoplastic lesions in chemically induced colorectal cancer in the rat, Br. J. Surg. 73:487–489 (1986).

    Article  PubMed  CAS  Google Scholar 

  30. P. Hilgard and B. Maat, Mechanism of lung tumour colony reduction caused by coumarin anticoagulation, Euron. J. Cancer 15:183–187 (1979).

    CAS  Google Scholar 

  31. L.R. Zacharski, W.G. Henderson, F.R. Rickles, W.B. Forman, C.J. Cornell, R.J. Forcier, R.L. Edwrds, E. Headley, S.-H. Kim, J.F. O’Donnell, R. O’Dell, K. Tornyos, and H. Kwaan, Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate, Final Report of VA cooperative study #75, Cancer 53:2046–2052 (1983).

    Google Scholar 

  32. R.L. Edwards and F.R. Rickles, Delayed hypersensitivity in man: Effects of systemic anticoagulation. Science 200:541–543 (1978).

    Article  PubMed  CAS  Google Scholar 

  33. M.M. Bern, A. Bothe, B. Bistrian, C.D. Champagne, M.S. Keane, and G.L. Blackburn, Prophylaxis against central vein thrombosis with low-dose warfarin. Surgery 99:216–221 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology (B-022), University of California at San Diego, La Jolla, CA, 92093, USA

    Paul A. Price

Authors
  1. Paul A. Price
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New York University School of Medicine, New York, New York, USA

    Stanford Wessler

  2. Cornell University Medical College, New York, New York, USA

    Carl G. Becker

  3. Mt. Sinai School of Medicine of the City University of New York, New York, New York, USA

    Yale Nemerson

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Science+Business Media New York

About this chapter

Cite this chapter

Price, P.A. (1987). Warfarin and Bone: Implications for Rational Strategies to Selectively Antagonize the Action of Vitamin K in Target Tissues. In: Wessler, S., Becker, C.G., Nemerson, Y. (eds) The New Dimensions of Warfarin Prophylaxis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5985-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5985-3_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-5987-7

  • Online ISBN: 978-1-4757-5985-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation